Table 3 Detailed information about patients receiving convalescent plasma treatment
Patients | ||||||||
|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
Complications prior to CP treatment | Bacterial pneumonia | Hyperlipidaemia | None | Bacterial pneumonia, ARDS, MODS, LDVT | Fungal pneumonia, cardiac failure, anemia | None | Bacterial pneumonia | Fungal pneumonia, LDVT |
Clinical classification prior to CP treatment | Severe | Critical | Severe | Critical | Severe | Severe | Severe | Severe |
Days of CP transfusion from symptom onset | 30 | 12 | 17 | 23 | 34 | 26 | >9 | 28 |
Total transfusion volume, mL | 400 | 400 | 400 | 300 | 400 | 200 | 200 | 200 |
1st transfusion | ||||||||
CP donor | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 6 |
Time | Feb 18, 00:10 a.m. | Feb 18, 00:15 a.m. | Feb 29, 10:00 a.m. | Feb 20, 14:05 p.m. | Mar 5, 20:10 p.m. | Feb 23, 13:20 p.m. | Feb 23, 13:10 p.m. | Feb 23, 13:10 p.m. |
Dose, mL | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
2nd transfusion | ||||||||
CP donor | 2 | 1 | 3 | 4 | 5 | – | – | – |
Time | Feb 18, 12:50 p.m. | Feb 18, 12:50 p.m. | Mar 1, 10:05 a.m. | Feb 21, 15:05 p.m. | Mar 6, 8:45 a.m. | – | – | – |
Dose, mL | 200 | 200 | 200 | 100 | 200 | – | – | – |
Clinical outcome | Discharge | Discharge | Discharge | Remain hospitalized | Discharge | Discharge | Discharge | Discharge |
Length of hospital stay, days | 36 | 20 | 18 | - | 35 | 28 | 28 | 30 |
